Advertisement

Topics

Pfizer and BMS Score Approval for Orthopedic Drug

11:37 EDT 20 May 2011 |

The European Commission has approved apixaban (Eliquis), developed by Pfizer and Bristol-Myers Squibb, for the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery, according to a press release. The two New York companies have an alliance to develop the drug, which is a new oral direct [...]

Original Article: Pfizer and BMS Score Approval for Orthopedic Drug

NEXT ARTICLE

More From BioPortfolio on "Pfizer and BMS Score Approval for Orthopedic Drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...